Cormorant Asset Management, LP - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,133,000
-41.1%
520,183
-48.0%
0.31%
-36.5%
Q4 2016$3,620,0001,000,0000.49%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,133,583$4,104,0003.61%
GREAT POINT PARTNERS LLC 1,537,873$5,567,0001.14%
BVF INC/IL 1,392,720$5,042,0001.01%
Boxer Capital, LLC 525,000$1,901,0000.74%
Vivo Capital, LLC 500,000$1,810,0000.60%
Healthcare Value Capital, LLC 150,000$543,0000.58%
Cormorant Asset Management, LP 1,000,000$3,620,0000.49%
Telemetry Investments, L.L.C. 120,807$437,0000.25%
Palo Alto Investors LP 1,162,473$4,208,0000.24%
NEA Management Company, LLC 1,298,274$4,700,0000.19%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders